Ninlaro

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 2 USDMF, 2 EU WC, 1 KDMF, 3 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

15 FDF Dossiers, 3 FDA Orange Book, 6 Europe, 3 Canada, 3 South Africa

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 2.3MG BASE, CAPSULE;ORAL - EQ 3MG BASE, CAPSULE;ORAL - EQ 4MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Kerry, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 11 Lubricants & Glidants, 9 Thickeners and Stabilizers, 8 Direct Compression, 5 Granulation, 5 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 4 Controlled & Modified Release, 3 Coating Systems & Additives, 2 Film Formers & Plasticizers, 2 Chewable & Orodispersible Aids, 2 Taste Masking, 1 Rheology Modifiers, 1 Emulsifying Agents